Nagai, T., Naiki, T., Iida, K., Etani, T., Ando, R., Hamamoto, S., . . . Yasui, T. (2018). Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade. Prostate Int.
Citação norma ChicagoNagai, Takashi, et al. "Early Abiraterone Acetate Treatment Is Beneficial in Japanese Castration-resistant Prostate Cancer After Failure of Primary Combined Androgen Blockade." Prostate Int 2018.
Citação norma MLANagai, Takashi, et al. "Early Abiraterone Acetate Treatment Is Beneficial in Japanese Castration-resistant Prostate Cancer After Failure of Primary Combined Androgen Blockade." Prostate Int 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.